Issuer · CIK 0001636282
SYRE — Spyre Therapeutics, Inc.
Recent filings
- Jun 4, 2026·Form 4·Sell$625K
SYRE/Spyre Therapeutics, Inc.
Sloan Sheldon · Chief Medical Officer
68conviction - Jun 4, 2026·Form 4·Sell$574.5K
SYRE/Spyre Therapeutics, Inc.
Turtle Cameron · Chief Executive Officer
38conviction - Jun 4, 2026·Form 4·Sell$223.4K
SYRE/Spyre Therapeutics, Inc.
Burrows Scott L · Chief Financial Officer
62conviction - May 29, 2026·Form 4·Other—
SYRE/Spyre Therapeutics, Inc.
Fairmount Funds Management LLC · director
Mechanical filing
AI thesis skipped - May 29, 2026·Form 4·Other—
SYRE/Spyre Therapeutics, Inc.
Albers Jeffrey W. · director
Mechanical filing
AI thesis skipped - May 29, 2026·Form 4·Other—
SYRE/Spyre Therapeutics, Inc.
HENDERSON MICHAEL THOMAS · Chief Executive Officer
Mechanical filing
AI thesis skipped - May 29, 2026·Form 4·Other—
SYRE/Spyre Therapeutics, Inc.
Stelzer Laurie · director
Mechanical filing
AI thesis skipped - May 29, 2026·Form 4·Other—
SYRE/Spyre Therapeutics, Inc.
McKenna Mark C. · director
Mechanical filing
AI thesis skipped - May 29, 2026·Form 4·Other—
SYRE/Spyre Therapeutics, Inc.
Milligan Sandra · director
Mechanical filing
AI thesis skipped - May 9, 2026·Form 4·Sell$2.5M
SYRE/Spyre Therapeutics, Inc.
HENDERSON MICHAEL THOMAS · Chief Executive Officer
38conviction - May 2, 2026·Form 4·Sell$892.1K
SYRE/Spyre Therapeutics, Inc.
Burrows Scott L · Chief Financial Officer
Mechanical filing
AI thesis skipped - May 1, 2026·Form 4·Other$2.2M
SYRE/Spyre Therapeutics, Inc.
Sloan Sheldon · Chief Medical Officer
12conviction - Apr 3, 2026·Form 4·Sell$607.3K
SYRE/Spyre Therapeutics, Inc.
Turtle Cameron · Chief Executive Officer
22conviction